Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine...

Bright Minds Biosciences Establishes Scientific Advisory Board, Comprising Five Preeminent Physicians...

Bright Minds Biosciences to Host Key Opinion Leader Symposium on Dravet...

Numinus Applies for International Patent Filing of Psychedelics Production Process

Small Pharma Reports Highlights for the Fiscal Year Ended February 28,...

Field Trip Health Ltd. Announces Increased Participation in Arrangement Financing and...

Mindmed Announces Voting Results for Annual General and Special Meeting

GH Research Reports First Quarter 2022 Financial Results and Provides Business...

COMPASS Pathways presents largest ever study of psilocybin therapy, at American...

Incannex announces positive results from phase 2 clinical trial investigating the...

Load more